Rachelle Suzanne Jacques
CIK: 0001772610
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 11, 2026QURE
uniQure N.V.
Sale(S)Direct2K shares at avg. $27.06$54K - Jun 10, 2026QURE
uniQure N.V.
Award(A)Direct7.6K shares- - May 19, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Award(A)Direct3.8K shares- - Jun 20, 2025QURE
uniQure N.V.
Sale(S)Direct2.1K shares at avg. $14.45$31K - Jun 11, 2025QURE
uniQure N.V.
Award(A)Direct8K shares- - May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
Award(A)Direct4.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  QURE uniQure N.V. | Sale(S) | 1,993 | $27.06 | $53,931 | Direct |
| Jun 10, 2026 | QURE uniQure N.V. | Award(A) | 7,550 | - | $0 | Direct |
| May 19, 2026 |  CRBP Corbus Pharmaceuticals Holdings, Inc. | Award(A) | 3,800 | - | $0 | Direct |
| Jun 20, 2025 | QURE uniQure N.V. | Sale(S) | 2,112 | $14.45 | $30,518 | Direct |
| Jun 11, 2025 | QURE uniQure N.V. | Award(A) | 7,970 | - | - | Direct |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Award(A) | 4,800 | - | - | Direct |
1-6 of 6 transactions
About Jacques Rachelle Suzanne
Jacques Rachelle Suzanne (SEC CIK 0001772610) files insider reports with the SEC as Director of uniQure N.V. (QURE) and Director of Corbus Pharmaceuticals Holdings, Inc. (CRBP).
Signal8 holds 5 ownership filings by Jacques Rachelle Suzanne, all Form 4s, filed between Jun 2, 2025 and Jun 12, 2026. Those filings report 6 transactions, from May 30, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jacques Rachelle Suzanne's filings is in AMSTERDAM.
Recent filings by Jacques Rachelle Suzanne
- Jun 11, 2026: Open-market sale of QURE shares (Form 4, code S).
- Jun 10, 2026: Grant or award of QURE shares (Form 4, code A).
- May 19, 2026: Grant or award of CRBP shares (Form 4, code A).
- Jun 20, 2025: Open-market sale of QURE shares (Form 4, code S).
- Jun 11, 2025: Grant or award of QURE shares (Form 4, code A).
Other insiders filing for uniQure N.V. (QURE)
- Abi-Saab Walid, Chief Medical Officer
- Kapusta Matthew C, CEO, Managing Director
- Kaye Jack, Director
- Balachandran Madhavan, Director
- Potts Jeannette, Chief Legal Officer
- Meek David D., Director